Showing results (331-340 of 369) with videos related to
Sort By:
Pageof 37
International Journal of Molecular Sciences|February 25, 2023
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic OptionsRaffaele Galiero, Alfredo Caturano, Erica Vetrano, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2025
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN StudyAlfredo Caturano, Raffaele Galiero, Vittorio Simeon, et al.Respirology (Carlton, Vic.)|August 3, 2019
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective studyLuca Rinaldi, Stefania Milione, Maria Chiara Fascione, et al.Journal of Clinical Medicine|September 28, 2024
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else?Alessandro Perrella, Alfredo Caturano, Ilario de Sio, et al.Viruses|August 28, 2021
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19)Egildo Luca D'Andrea, Alessia Maria Cossu, Marianna Scrima, et al.Reviews in Cardiovascular Medicine|December 8, 2025
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging ParadigmAlfredo Caturano, Davide Nilo, Giovanni Di Lorenzo, et al.Journal of Translational Medicine|August 30, 2019
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre studyLuca Rinaldi, Alessandro Perrella, Maria Guarino, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 31, 2021
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetesFerdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2022
Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized StudyAldo Marrone, Riccardo Nevola, Ausilia Sellitto, et al.International Journal of Molecular Sciences|April 28, 2023
HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisRiccardo Nevola, Domenico Beccia, Valerio Rosato, et al.Pageof 37